AlphAIalphai — Financial news for AI agents
theglobeandmail.comSEP 11 min read$ALGN

Align Tech adds Quentin Blackford to board

Align Technology (ALGN) added Quentin Blackford, CEO of iRhythm Technologies, to its board, expanding it to 11 members. Blackford brings healthcare and digital innovation experience. Director Andrea L. Saia will retire in September 2026, reducing the board to 10 members.

Original reporting
theglobeandmail.com
Published Sep 1, 2026, 8:36 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 3, 2026, 11:45 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Align Tech adds Quentin Blackford to board — source image
Source · theglobeandmail.com
Decision brief

The 30-second read

$ALGNNeutralLow
01

Why it matters

The appointment adds seasoned digital‑health leadership, potentially guiding future product diversification.

02

Market read

Board changes are modest news; may have slight influence on investor sentiment but unlikely to drive price moves.

03

What to watch

Blackford's experience at Dexcom and iRhythm could accelerate Align's move into broader health monitoring.

Relevance 7/10Novelty 6/10Timing: effective August 27 2026

Background

Align Technology (ALGN) is a leading provider of clear aligner orthodontic solutions.

Company-level read

Ticker impact

$ALGNNeutralMedium confidence
Context

Align Technology appointed Quentin Blackford to its board, expanding the board to eleven members.

Expected impact

minimal short‑term impact, potential upside if new expertise drives growth initiatives.

Evidence & confidence

Executive appointments are typically low‑impact unless tied to major strategic shifts.

Market effects

Sector

Adds digital health expertise to Align, may signal focus on healthcare‑tech integration.

Regional

U.S. dental aligner market sees modest governance update.

Global

Limited; primarily relevant to Align shareholders and dental‑tech investors.

Counterpoint

What could challenge this read

Board change unlikely to affect valuation; investors may ignore.

Key entities

  • Executive
    Quentin Blackford

    President and CEO of iRhythm Technologies, former senior executive at Dexcom, NuVasive, Zimmer Holdings.

  • Director
    Andrea L. Saia

    Long‑serving board member retiring September 23, 2026.

Read at source← All news

Related articles

AUG 27
$ALGNMed

Are Wall Street Analysts Bullish on Align Technology Stock?

Align Technology (ALGN), a medical device company, has underperformed the broader market and healthcare sector ETF over the past 52 weeks. Analysts expect its adjusted EPS to grow 10.9% YoY by 2026, with a consensus 'Moderate Buy' rating. The mean price target is $207.07, implying a 30.1% upside. Piper Sandler maintained a 'Buy' rating with a $235 target.

barchart.com2 min
AUG 12
$ALGNMed

Align Technology Prevails in China Patent Infringement Action Against Angelalign

Align Technology said a Jinan Intermediate People’s Court issued a first-instance ruling on Aug. 10, 2026 in a China patent case against Angel. The court found Angel’s MasterForce and ATreat systems infringe Align’s CN113693748B patent and ordered Angel to stop use, manufacturing, and sales, awarding RMB 10 million in damages. Angel can appeal to China’s Supreme People’s Court.

antaranews.com4 min
AUG 12
$ALGNMed

Align Technology, Inc.: Align Technology Prevails in China Patent Infringement Action Against Angelalign

Align Technology (Nasdaq: ALGN) said China’s Jinan Intermediate People’s Court ruled in its favor in a patent infringement case against Angelalign’s China subsidiaries. The court found Angel infringed Align’s CN113693748B patent tied to extraction-gap-closure technology, ordering a stop to use and sales in China and awarding RMB 10 million in damages. Angel can appeal.

finanznachrichten.de4 min
AUG 10
$DDDMed

3D Printing Financials: 3D Systems, Prodways, and Align Build on Positive Momentum - 3DPrint.com

3D Systems reported Q2 revenue of $94.6M, flat YoY, with healthcare up 6.8% and aerospace/defense and data center infrastructure each growing over 20%. Adjusted EBITDA loss narrowed to $0.8M. It expects Q3 revenue of $96M to $99M. Prodways posted Q2 revenue of €10.5M (+5% YoY) and plans a €20M buyback. Align Technology reported record Q2 revenue of just over $1.05B (+4.3%), with clear aligner revenue up 8.2% and 2026 revenue growth guidance of 3% to 4%.

3dprint.com6 min
AUG 8
$ALGNMedAI 9/10

Align Technology (ALGN) Q2 2026 Earnings Call Transcript

Align Technology (ALGN) reported Q2 2026 revenue of $1,056.2 million, up 4.3% y/y, driven by record Clear Aligner volumes and higher ASPs. Clear Aligner revenue rose 8.2% to $870.9 million on 691,785 cases. Systems and Services revenue fell 10.8% to $185.3 million. Q3 revenue guidance is $1.00 to $1.02 billion; full-year growth 3% to 4%.

aol.com7 min